Interleukin-17 inhibition: role in psoriasis and inflammatory bowel disease

Interleukin-17 inhibition: role in psoriasis and inflammatory bowel disease

Introduction: Interleukin 17 (IL-17) antagonism provides a highly effective approach for treating psoriasis. Exacerbations of inflammatory bowel disease have been reported in anti-IL-17 psoriasis trials. Aim: To characterize the relationship between IL-17 inhibition and inflammatory bowel disease. M...

Full description

Bibliographic Details
Main Authors: Megan Hohenberger, Leah A. Cardwell, Elias Oussedik, Steven R. Feldman
Format: Article
Language:English
Published: Taylor & Francis Group 2018-01-01
Series:Journal of Dermatological Treatment
Subjects:
biologics
secukinumab
ixekizumab
brodalumab
Online Access:http://dx.doi.org/10.1080/09546634.2017.1329511

Internet

http://dx.doi.org/10.1080/09546634.2017.1329511

Similar Items